293 related articles for article (PubMed ID: 11086177)
1. The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs.
Masuda Y; Nakaya M; Aiuchi T; Hashimoto S; Nakajo S; Nakaya K
Leuk Res; 2000 Nov; 24(11):937-50. PubMed ID: 11086177
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.
Shiah SG; Chuang SE; Kuo ML
Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861
[TBL] [Abstract][Full Text] [Related]
3. Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death.
Ozaki I; Tani E; Ikemoto H; Kitagawa H; Fujikawa H
J Biol Chem; 1999 Feb; 274(9):5310-7. PubMed ID: 10026138
[TBL] [Abstract][Full Text] [Related]
4. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
5. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2.
Chan WH; Yu JS; Yang SD
Biochem J; 2000 Oct; 351(Pt 1):221-32. PubMed ID: 10998365
[TBL] [Abstract][Full Text] [Related]
7. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
Boldt S; Weidle UH; Kolch W
Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
[TBL] [Abstract][Full Text] [Related]
8. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.
Zhang JP; Wong CK; Lam CW
Clin Exp Immunol; 2000 Oct; 122(1):20-7. PubMed ID: 11012613
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis.
Andreka P; Zang J; Dougherty C; Slepak TI; Webster KA; Bishopric NH
Circ Res; 2001 Feb; 88(3):305-12. PubMed ID: 11179198
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
Bae MA; Pie JE; Song BJ
Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3.
Schroeter H; Spencer JP; Rice-Evans C; Williams RJ
Biochem J; 2001 Sep; 358(Pt 3):547-57. PubMed ID: 11535118
[TBL] [Abstract][Full Text] [Related]
13. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
15. Analysis of caspases that are activated during apoptosis in leukemia U937 cells in response to geranylgeraniol.
Nakaya M; Masuda Y; Mihara S; Aiuchi T; Shibayama-Imazu T; Nakajo S; Nakaya K
Anticancer Res; 1999; 19(6B):5063-8. PubMed ID: 10697511
[TBL] [Abstract][Full Text] [Related]
16. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin.
Assefa Z; Vantieghem A; Declercq W; Vandenabeele P; Vandenheede JR; Merlevede W; de Witte P; Agostinis P
J Biol Chem; 1999 Mar; 274(13):8788-96. PubMed ID: 10085120
[TBL] [Abstract][Full Text] [Related]
17. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis.
Seimiya H; Mashima T; Toho M; Tsuruo T
J Biol Chem; 1997 Feb; 272(7):4631-6. PubMed ID: 9020192
[TBL] [Abstract][Full Text] [Related]
18. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
Yu C; Rahmani M; Dent P; Grant S
Exp Cell Res; 2004 May; 295(2):555-66. PubMed ID: 15093752
[TBL] [Abstract][Full Text] [Related]
19. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
Stadheim TA; Xiao H; Eastman A
Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
